Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polydatin injection in severe burn patients with SIRS
CTR20132636Phase 2Completed
- Sponsor
- Shenzhen Neptunus Pharmaceutical
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of polydatin in burn injury, Systemic Inflammatory Response Syndrome (SIRS), sponsored by Shenzhen Neptunus Pharmaceutical. Started Apr 2014; status: completed.
02
Drugs
polydatin
03
Conditions
burn injurySystemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on CTR20132636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132636.